RY 161.29 0.8315% SHOP 116.7 1.6108% TD 83.65 0.553% ENB 61.82 1.2613% BN 68.755 0.8729% TRI 248.88 1.754% CNQ 38.22 0.6054% CP 103.1 0.4775% CNR 138.9 -0.0576% BMO 129.44 1.1013% BNS 65.52 0.7845% CSU 4654.3901 1.9582% CM 81.81 1.3755% MFC 40.37 1.0766% ATD 69.68 -0.9805% NGT 76.14 0.2106% TRP 67.93 2.0123% SU 46.68 0.4735% WCN 273.82 0.8397% L 206.99 -1.499%
Last update at 2025-04-15T16:56:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Reflecting On Vertical Software Stocks’ Q4 Earnings: nCino (NASDAQ:NCNO)
Tue 15 Apr 25, 09:04 AMIntuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
Mon 14 Apr 25, 01:39 PMVeeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Thu 10 Apr 25, 03:38 PMQ4 Earnings Review: Vertical Software Stocks Led by Upstart (NASDAQ:UPST)
Thu 10 Apr 25, 09:07 AM2 Top Growth Stocks to Buy and Hold for the Next 20 Years
Sun 06 Apr 25, 12:00 PMWhy Is Veeva (VEEV) Down 6.2% Since Last Earnings Report?
Fri 04 Apr 25, 03:30 PMVeeva Systems (VEEV) Benefited in Q4 From Strong Execution
Fri 04 Apr 25, 12:44 PMWhy a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
Thu 03 Apr 25, 08:50 PMNew Strong Buy Stocks for April 3rd
Thu 03 Apr 25, 10:40 AMBest Momentum Stocks to Buy for April 3rd
Thu 03 Apr 25, 07:47 AM| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Income before tax | 509.10M | 512.31M | 393.99M | 313.70M | 238.64M |
| Minority interest | - | - | - | - | - |
| Net income | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Selling general administrative | 217.59M | 171.51M | 149.11M | 114.27M | 86.41M |
| Selling and marketing expenses | 348.69M | 288.06M | 235.01M | 190.33M | 148.87M |
| Gross profit | 1545.65M | 1347.10M | 1056.14M | 800.71M | 616.93M |
| Reconciled depreciation | 29.12M | 27.45M | 29.45M | 19.86M | 14.07M |
| Ebit | 459.09M | 505.50M | 377.79M | 286.22M | 222.87M |
| Ebitda | 488.21M | 532.94M | 407.25M | 314.04M | 236.94M |
| Depreciation and amortization | 29.12M | 27.45M | 29.45M | 27.82M | 14.07M |
| Non operating income net other | - | - | 16.20M | 27.48M | 15.78M |
| Operating income | 459.09M | 505.50M | 377.79M | 286.22M | 222.87M |
| Other operating expenses | 1695.97M | 1345.28M | 1087.28M | 817.86M | 639.34M |
| Interest expense | -50.00500M | 14.73M | 16.20M | 27.48M | 0.00000M |
| Tax provision | 21.39M | 84.92M | 13.99M | 12.58M | 8.81M |
| Interest income | 45.86M | 14.73M | 15.86M | 25.18M | 15.39M |
| Net interest income | 45.86M | 14.73M | 15.86M | 25.18M | 15.39M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 21.39M | 84.92M | 13.99M | 12.58M | 8.81M |
| Total revenue | 2155.06M | 1850.78M | 1465.07M | 1104.08M | 862.21M |
| Total operating expenses | 1086.56M | 841.60M | 678.35M | 514.49M | 394.06M |
| Cost of revenue | 609.40M | 503.68M | 408.93M | 303.37M | 245.28M |
| Total other income expense net | 50.01M | 6.82M | 16.20M | 27.48M | 15.78M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Net income applicable to common shares | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Total assets | 4804.30M | 3816.47M | 3046.07M | 2271.78M | 1653.77M |
| Intangible assets | 82.48M | 101.94M | 114.59M | 134.60M | 24.52M |
| Earning assets | - | - | - | - | - |
| Other current assets | 81.46M | 36.68M | 35.61M | 21.87M | 21.67M |
| Total liab | 1088.04M | 904.83M | 779.75M | 606.18M | 416.02M |
| Total stockholder equity | 3716.25M | 2911.64M | 2266.32M | 1665.59M | 1237.75M |
| Deferred long term liab | 31.82M | 33.11M | 42.07M | 2.42M | 30.87M |
| Other current liab | 84.53M | 77.70M | 63.98M | 52.85M | 28.66M |
| Common stock | 0.00200M | 0.00200M | 0.00200M | 0.00100M | 0.00100M |
| Capital stock | 0.00200M | 0.00200M | 0.00200M | 0.00100M | 0.00100M |
| Retained earnings | 2214.75M | 1727.05M | 1299.66M | 919.66M | 619.20M |
| Other liab | 31.57M | 20.44M | 12.40M | 10.20M | 14.99M |
| Good will | 439.88M | 439.88M | 436.03M | 438.53M | 95.80M |
| Other assets | 207.48M | 63.33M | 74.05M | 63.64M | 45.06M |
| Cash | 886.47M | 1138.04M | 730.50M | 476.73M | 550.97M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1006.80M | 840.78M | 715.95M | 551.17M | 401.02M |
| Current deferred revenue | 869.28M | 731.75M | 616.99M | 468.89M | 356.36M |
| Net debt | -825.48900M | -1083.45200M | -667.38600M | -421.90500M | -550.97100M |
| Short term debt | 11.31M | 10.98M | 11.72M | 10.01M | 6.89M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 60.98M | 54.59M | 63.12M | 54.83M | - |
| Other stockholder equity | 1532.63M | 1196.55M | 965.67M | 745.48M | 617.62M |
| Property plant equipment | 105.15M | 104.14M | 110.57M | 54.75M | 54.97M |
| Total current assets | 3969.31M | 3107.18M | 2310.83M | 1531.12M | 1433.41M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | 3193.90M | 2369.82M | 1715.70M | 1092.46M | 1117.42M |
| Short term investments | 2216.16M | 1238.06M | 933.12M | 610.01M | 539.19M |
| Net receivables | 785.23M | 694.40M | 611.59M | 422.51M | 321.59M |
| Long term debt | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Accounts payable | 41.68M | 20.35M | 23.25M | 19.42M | 9.11M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -31.12900M | -11.95800M | 0.99M | 0.46M | 0.93M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 0.00200M | 0.00100M | 0.00100M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | 1299.66M | 919.66M | 619.20M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 70.78M | 58.23M | 17.88M | 16.18M | 8.25M |
| Deferred long term asset charges | - | - | 42.07M | 35.59M | 36.81M |
| Non current assets total | 834.98M | 709.28M | 735.24M | 740.65M | 220.35M |
| Capital lease obligations | 60.98M | 54.59M | 63.12M | 54.83M | - |
| Long term debt total | - | - | - | 0.36M | - |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Investments | -1007.68300M | -324.15800M | -333.63400M | -64.42700M | -94.05000M |
| Change to liabilities | 161.90M | 113.15M | 148.23M | -10.43200M | 95.89M |
| Total cashflows from investing activities | -1007.68300M | -346.15200M | -333.63400M | -516.91000M | -103.86900M |
| Net borrowings | - | -0.38400M | -1.03900M | -0.98400M | -0.98400M |
| Total cash from financing activities | -19.37600M | -4.14000M | 33.82M | 10.01M | 25.91M |
| Change to operating activities | -60.66100M | -14.68100M | -32.40200M | -49.79300M | -25.48400M |
| Net income | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Change in cash | -251.57500M | 409.51M | 251.91M | -72.38100M | 230.79M |
| Begin period cash flow | 1141.22M | 731.71M | 479.80M | 552.18M | 321.39M |
| End period cash flow | 889.65M | 1141.22M | 731.71M | 479.80M | 552.18M |
| Total cash from operating activities | 780.47M | 764.46M | 551.25M | 437.38M | 310.83M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 29.12M | 27.45M | 29.45M | 27.82M | 14.07M |
| Other cashflows from investing activities | - | - | -8.68300M | -449.37000M | -1.37900M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | -22.64800M | -37.98000M | -10.68000M |
| Change to account receivables | -72.17700M | -67.02000M | -174.06700M | -55.53100M | -78.99500M |
| Sale purchase of stock | - | - | 34.86M | 10.99M | 25.91M |
| Other cashflows from financing activities | -19.37600M | -3.75600M | 34.86M | 10.99M | 25.91M |
| Change to netincome | 234.21M | 262.91M | 196.76M | 109.37M | 68.36M |
| Capital expenditures | 2.49M | 2.49M | 0.57M | 4.32M | 9.82M |
| Change receivables | - | - | -174.06700M | -55.53100M | -78.99500M |
| Cash flows other operating | - | - | -32.08000M | 55.75M | -34.27700M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | 251.43M | -69.52500M | 232.87M |
| Change in working capital | 7.34M | 20.66M | -75.64600M | -18.18200M | -17.37800M |
| Stock based compensation | 351.91M | 234.64M | 185.00M | 115.91M | 76.42M |
| Other non cash items | 31.90M | 43.25M | 33.49M | 17.37M | 15.97M |
| Free cash flow | 777.98M | 761.97M | 551.81M | 433.05M | 301.01M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc Class A |
-1.115 0.50% | 222.54 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| GEHC GE HealthCare Technologies Inc. |
-1.34 2.08% | 63.05 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| MTHRF M3 Inc |
- -% | 9.45 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
0.04 0.69% | 5.85 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
| TEM Tempus AI, Inc. Class A Common Stock |
-1.28 2.97% | 41.85 | - | - | 13.29 | 80.58 | 13.27 |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
4280 Hacienda Drive, Pleasanton, CA, United States, 94588
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter P. Gassner | Founder, CEO & Director | 1965 |
| Mr. Thomas D. Schwenger | Pres & COO | 1968 |
| Mr. Brent R. Bowman | Chief Financial Officer | 1967 |
| Mr. Alan V. Mateo | Exec. VP of Global Sales | 1962 |
| Ms. Michele O'Connor | Chief Accounting Officer | 1977 |
| Mr. Pinal Patel | Chief Information Officer | NA |
| Mr. Ato Garrett | Sr. Director of Investor Relations | NA |
| Mr. Jonathan W. Faddis | Sr. VP, Gen. Counsel & Corp. Sec. | 1972 |
| Mr. Jacques Mourrain Ph.D. | VP of Quality & Compliance | NA |
| Ms. Eleni Nitsa Zuppas | Chief Marketing Officer | 1970 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA
NZ
UK
US
AU
IND
Please wait processing your request...